Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors

D. Tepper, S. M. Greenberg, M. Packer, M. Gheorghiade, J. Young

Research output: Contribution to journalComment/debate

Abstract

In this section, the use of digoxin is discussed. Despite evidence from controlled trials supporting its value, the use of digoxin remains controversial. The withdrawal of digoxin carries considerable risk for patients with chronic heart failure and impaired systolic function who have remained clinically stable while receiving digoxin and angiotensin- converting-enzyme inhibitors.

Original languageEnglish (US)
Number of pages1
JournalCardiovascular Reviews and Reports
Volume14
Issue number9
StatePublished - Jan 1 1993

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors'. Together they form a unique fingerprint.

  • Cite this